Member Info for The-Oracle

1.

https://www.streamtvinsider.com/advertising/netflix-plans-house-ad-tech-partners-trade-desk-magnite-google

2.

https://www.thetradedesk.com/press-room/netflix-announces-new-partnership-with-the-trade-desk

This is from last year. Our deal with Rembrand, perfectly positions Miri to capitalise on this through Trade Desk in Europe and the rest of the world M.E etc

Apart from the 30%, 20% for the next three years from Rembrand. Trade Desk and possible other opportunities opens up a massive new market for us. It would be silly not to. This deal makes sense more and more.

So all we need is an announcement with Trade Desk (Anyone going to the AGM, worth asking) and Netflix is part of the package.

Can't imagine ehat that will do to the sp

"Following the discussion about changes to the trials and what was the reasoning, below is an extract from Principle 3 of Sareums Corporate Governance.

The executive directors are in regular dialogue with collaborators and potential license partners regarding the data requirements for a drug license package. Feedback from these discussions is fed into future development plans as part of an ongoing process.

So make of it what you will."

Steadydanny off advfn

Damn

This was asked and answerd at the AGM.

Serious negotiations indeed.

UK faces a swarm of takeover bids in the new year: one in three AIM stocks at risk, says Peel Hunt.

Go on SAR, fire the starting pistol

https://www.dailymail.co.uk/money/markets/article-14211559/UK-faces-swarm-takeover-bids-new-year-One-three-AIM-stocks-risk-says-Investment-bank-Peel-Hunt.html

Roger Meier

Switzerland, hmm rings bells

PC1954,

Take it easy and speedy recovery.

Glad you're through the worst of it.

Yep Just listened to that.

He doesn't quite say the peer review is seperate from the clinical study report. But he does state they are this side of the year. So, that's just better news than i initially believed.

Cheers for clearing that up Leggster, to many good days ahead

Leggster,

According to Sareum. "Clinical Study Report" is this Q4.

The Journal and Peer Review is as Krone mentioned. 3 to 6 months later.

Note, this is following with what the board have said and is posted on Sareum website.

Gla

"If the price is right"

When your other holding drops on news contrary to your predictions and hopes, gets you upset and frustrated so you find another stock to bash to take out your anger.

Sad life to live, worth sitting in that sink you let sink in, before a mirror and reflecting on your life before it sinks any further, now let that sink in.

May your holding recover, afterall, we can all win.

I have no sinks left.

Batonrouge, common situation to be in these days.

Fully funded

Clear path forward

Good set of news incoming.

Looking forward to the SP recovering.

Might have been Pfizer trying to remove the better competition but trapped on how to tell its shareholders Sareum's 1801 is better than Brepocitinib. A bit like boasting about your new 30inch LED tv with 3D glasses (Brep) and the new trainee shows up with a 100inch 8K UHDR QD-OLED Smart TV with Ai (1801)

The coming publishment in the journal is the PR we need. And the fact we have committed to further toxicity studies, P2 ready.

Is a deal very likely in the next 6 months. Tick stock.

I am honestly satisfied with yesterday's meeting, and it was world Psoriasis day too.

*They're

Well put HBD,

What I've said and live by.

Some will sit, complain it's taking too long. Get their first plate and spout vile about the taste while ordering another plate and asking for their money back on the first plate that was terrible (their still eating it)

Sell and move on, if you can't sell the company to a new comer, hate the board, have nothing good to say or find in it.

Why are you holding, utter buffoonery.

All eyes on SRA737

Gla

Not the hoped for outcome for a deal but the next best where we go it alone. More HNWIs, thought they would stick around or show up and the mention of institutions.

A bit more clarity would have been great. Just a further wait. Had plans but I am happy with this, makes sense if Pharmas want to see more in a Phase 2.

More patients and patience, in Tim we Trust.

Strangely, I feel encouraged looking forward by the delay and almost more optimistic because of it. Almost like no news is good news morphing into the longer the wait the bigger the deal.

At this point, it is what it is. A lot of news is due in the next 3 months. All at once or one at a time. Who has 737, are they after 1801, therefore everything. T/O?

Gla

Possibly not because in cases where it doesn't complete for various reasons. Business as usual would require it to be published.

Enki, each to their own, as we each have a life. I have points to take profit as everyone should have but a good portion will remain in SAR till the end as am sure many LTHs understand. That's like ending a 14 year fast with an appetizer and walking off on an empty rumbling stomach claiming to have eaten enough. No chance, till the FAT lady sings. Am in this till the end. Tim and Co are not spring chickens so their eyes are on the end game and they are well invested in Sareum. Hey Wolfy be nice to CT.

When Tim put the £800m value on EACH of our compounds. Does anyone remember at what phase he meant. Keeping in mind our business model. Now any completed trials would be in the billions so did he mean Phase 1 or Phase 2.

If he has that in mind for each, and we are guessing far less for everything. And he's in the negotiating room, i can only have faith.